Advanced glycation end products suppress osteoblastic differentiation of stromal cells by activating endoplasmic reticulum stress

Biochemical and Biophysical Research Communications

Volumn 438, Issue 3, 2013, Pages 463-467

  Tanaka, Ken ichiro ^a   Yamaguchi, Toru ^a   Kaji, Hiroshi ^b   Kanazawa, Ippei ^a   Sugimoto, Toshitsugu ^a  

^a SHIMANE UNIVERSITY FACULTY OF MEDICINE   (Japan)

^b KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Advanced glycation end products; Bone; Diabetes; Endoplasmic reticulum stress; Osteoblastogenesis; Stromal cells

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 6; ADVANCED GLYCATION END PRODUCT; ALKALINE PHOSPHATASE; COLLAGEN TYPE 1; MESSENGER RNA; OSTEOCALCIN; PROTEIN IRE1; THAPSIGARGIN; TRANSCRIPTION FACTOR OSTERIX;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; ENDOPLASMIC RETICULUM STRESS; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STROMA CELL;

ACTIVATING TRANSCRIPTION FACTOR; ADVANCED GLYCATION END PRODUCTS; ATF; BONE; DIABETES; ENDOPLASMIC RETICULUM STRESS; INOSITOL-REQUIRING TRANSMEMBRANE KINASE AND ENDONUCLEASE; IRE; OASIS; OLD ASTROCYTE SPECIFICALLY INDUCED SUBSTANCE; OSTEOBLASTOGENESIS; PERK; PROTEIN KINASE RNA-LIKE ENDOPLASMIC RETICULUM KINASE; STROMAL CELLS;

ANIMALS; APOPTOSIS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; ENDOPLASMIC RETICULUM STRESS; GLYCOSYLATION END PRODUCTS, ADVANCED; MICE; OSTEOBLASTS; STROMAL CELLS; THAPSIGARGIN;

EID: 84882842624     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.07.126     Document Type: Article

References (21)

1. Vestergaard P. Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes - a meta-analysis. Osteoporos. Int. 2007, 18:427-444.
2. Yamamoto M., Yamaguchi T., Yamauchi M., et al. Diabetic patients have an increased risk of vertebral fractures independent of BMD or diabetic complications. J. Bone Miner. Res. 2009, 24:702-709.
3. Singh R., Barden A., Mori T., et al. Advanced glycation end-products: a review. Diabetologia 2001, 44:129-146.
4. Vlassara H., Palace M.R. Diabetes and advanced glycation end products. J. Intern. Med. 2002, 251:87-101.
5. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001, 414:813-820.
6. Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes 2005, 54:1615-1625.
7. Ogawa N., Yamaguchi T., Yano S., et al. The combination of high glucose and advanced glycation end-products (AGEs) inhibits the mineralization of osteoblastic MC3T3-E1 cells through glucose-induced increase in the receptor for AGEs. Horm. Metab. Res. 2007, 39:871-875.
8. Franke S., Rüster C., Pester J., et al. Advanced glycation end products affect growth and function of osteoblasts. Clin. Exp. Rheumatol. 2011, 29:650-660.
9. Okazaki K., Yamaguchi T., Tanaka K., et al. Advanced glycation end products (AGEs), but not high glucose, inhibit the osteoblastic differentiation of mouse stromal ST2 cells through the suppression of osterix expression, and inhibit cell growth and increasing cell apoptosis. Calcif. Tissue Int. 2012, 91:286-296.
10. Gething M.J., Sambrook J. Protein folding in the cell. Nature 1992, 355:33-45.
11. Harding H.P., Zhang Y., Ron D. Protein translation and folding are coupled by an ndoplasmic-reticulum-resident kinase. Nature 1999, 397:271-274.
12. Calfon M., Zeng H., Urano F., et al. IRE1 couples endoplasmic reticulum load to secretory capacity by processing the XBP-1 mRNA. Nature 2002, 415:92-96.
13. Shen J., Chen X., Hendershot L., et al. ER stress regulation of ATF6 localization by dissociation of BiP/GRP78 binding and unmasking of Golgi localization signals. Dev. Cell 2002, 3:99-111.
14. Murakami T., Saito A., Hino S., et al. Signalling mediated by the endoplasmic reticulum stress transducer OASIS is involved in bone formation. Nat. Cell Biol. 2009, 11:1205-1211.
15. Saito A., Hino S., Murakami T., et al. A novel ER stress tranducer, OASIS, expressed in astrocytes. Antioxid. Redox Signal 2007, 9:563-571.
16. Murakami T., Kondo S., Ogata M., et al. Cleavage of the membrane-bound transcription factor OASIS in response to endoplasmic reticulum stress. J. Neurochem. 2006, 96:1090-1100.
17. Tohmonda T., Miyauchi Y., Ghosh R., et al. The IRE1α-XBP1 pathway is essential for osteoblast differentiation through promoting transcription of Osterix. EMBO Rep. 2011, 12:451-457.
18. Haze K., Yoshida H., Yanagi H., et al. Mammalian transcription factor ATF6 is synthesized as a transmembrane protein and activated by proteolysis in response to endoplasmic reticulum stress. Mol. Biol. Cell 1999, 10:3787-3799.
19. Yoshida H., Matsui T., Yamamoto A., et al. XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor. Cell 2001, 107:881-891.
20. Otsuka E., Yamaguchi A., Hirose S., et al. Characterization of osteoblastic differentiation of stromal cell line ST2 that is induced by ascorbic acid. Am. J. Physiol. 1999, 277:C132-138.
21. Yamaguchi A., Ishizuya T., Kintou N., et al. Effects of BMP-2, BMP-4, and BMP-6 on osteoblastic differentiation of bone marrow-derived stromal cell lines, ST2 and MC3T3-G2/PA6. Biochem. Biophys. Res. Commun. 1996, 220:366-371.